ERS/UNITE4TB webinar
28 November, 2024 | Online
13:00-14:00 CET

Chairs: Prof. Dr Raquel Duarte (Porto, Portugal), Prof. Dr Christoph Lange (Borstel, Germany)
Speaker: Dr Jessica Potter (London, United Kingdom)

Discussants: Mr Derrick Semugenze (Kampala, Uganda), Ms Omolola Adelowo (Lagos State, Nigeria)

Fees: Free for ERS members and non-members

Risk of TB is embodied across your life course - increased when you live and grow up or work in communities where incidence is high. Across Europe, but particularly in Western Europe, a large proportion of people affected by TB were originally born outside their country of diagnosis. Migrant populations are enormously diverse with a range of intersecting and specific vulnerabilities that shape both TB risk and access to healthcare. To improve TB care and prevention across Europe, we need to consider how best to prevent and treat TB in migrant populations.

Topics

TB and migration in a European context:

• Changing migration patterns
• Country differences
• Defining migrants and considering intersecting vulnerabilities

Considering prevention and care strategies that are particular to migrants:

• Screening programmes such as pre-entry, at-entry, post-entry for active and latent TB
• Active case finding in-country
• Passive case finding i.e., healthcare access and the broader contexts inc. laws/ policies/ rhetoric which shape migrants' experiences and delays to treatment

Educational aims

• This session will cover ways of thinking about migration health in general - categorisation and intersecting vulnerabilities.
• It will cover the epidemiology of TB in migrant populations across Europe and strategies to care and prevention relevant to migrant populations.
• It will take a critical approach to public health considering the impact of broader structural conditions on the experiences of migrants affected by TB and reflecting on the challenge of the competing agendas of (bio)security and healthcare provision.

Target audience

• Healthcare professionals
• Decision makers
• Policy makers
• Researchers
• TB community